Source · Select Committees · Business and Trade Committee
Recommendation 7
7
Acknowledged
India-UK trade agreement brings no significant changes to India's IP regime.
Conclusion
The Committee concludes that the Agreement does not introduce significant changes to India’s intellectual property regime that are likely to support growth in UK pharmaceutical exports. At the same time, the Committee recognises India’s role as a major producer of generic medicines and the importance of retaining some flexibility within its IP framework. The Committee welcomes the establishment of the Working Group on Intellectual Property established under the Agreement. (Conclusion, Paragraph 64)
Government Response Summary
The government states that the IP chapter goes beyond India's precedent in FTAs, supporting the economy through IP rights protection and enforcement. They will continue to advance this agenda through the Working Group on Intellectual Property Rights and a specialist Intellectual Property attaché in India.
Government Response
Acknowledged
HM Government
Acknowledged
The Intellectual Property (IP) chapter goes far beyond India’s precedent in FTAs, supporting our economy through protection and enforcement of IP rights. Locking in text which ties both countries to standards which go beyond the international baselines on IP provides business with the confidence that these standards will be maintained and provides the UK with an opportunity to hold India to account on these standards. This can encourage UK firms to begin exporting or expand exports to India, driving UK growth. HM Government and our specialist Intellectual Property attaché in India will continue to find ways to advance this agenda, aligned with UK business priorities. This will include through the establishment of a Working Group on Intellectual Property Rights, as outlined in the FTA.